Zyversa Therapeutics share price today

(ZVSA)

Zyversa Therapeutics share price is $1.15 & ₹97.98 as on 25 Dec 2024, 2.30 'hrs' IST

$1.15

▲

-0.02

(-1.71%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Zyversa Therapeutics share price in Dollar and Rupees. Guide to invest in Zyversa Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Zyversa Therapeutics. Get details on the Indian mutual funds that are investing in Zyversa Therapeutics. Get Analyst recommendations and forecasts along with all the Zyversa Therapeutics's financials.

Zyversa Therapeutics share price movements

Today's Low: $1.06
Today's High: $1.17
$1.15
7.83%
Downside
Day's Volatility :9.4%
Upside
1.71%
52 Weeks Low: $0.98
52 Weeks High: $25.00
$1.15
14.77%
Downside
52 Weeks Volatility :96.08%
Upside
95.4%

Zyversa Therapeutics Returns

Period	Zyversa Therapeutics Inc	Index (Russel 2000)
3 Months	-50.0%	0.0%
6 Months	-68.23%	0.0%
1 Year	-86.47%	0.0%
3 Years	-99.96%	-21.1%

Zyversa Therapeutics Key Statistics

in dollars & INR

Previous Close	$1.17
Open	$1.17
Today's High	$1.17
Today's Low	$1.06
Market Capitalization	$2.7M
Today's Volume	$43.1K
52 Week High	$25.0
52 Week Low	$0.9801
Revenue TTM	$0.0
EBITDA	$-10.2M
Earnings Per Share (EPS)	$491.97
PE Ratio	0.0
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-152.23%

How to invest in Zyversa Therapeutics from India?

It is very easy for Indian residents to invest directly in Zyversa Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Zyversa Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Zyversa Therapeutics or ZVSA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Zyversa Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Zyversa Therapeutics shares which would translate to 0.741 fractional shares of Zyversa Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Zyversa Therapeutics, in just a few clicks!

Returns in Zyversa Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Zyversa Therapeutics investment value today

Current value as on today

₹15,768

Returns

₹84,232

(-84.23%)

Returns from Zyversa Therapeutics Stock

₹86,471 (-86.47%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Zyversa Therapeutics

48%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Zyversa Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 48% more investors are searching Zyversa Therapeutics in the last 30 days versus the previous period.

Analyst Recommendation on Zyversa Therapeutics

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Zyversa Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Zyversa Therapeutics

What analysts predicted

Upside of 1639.13%

Current:

$1.15

Target:

$20.00

Insights on Zyversa Therapeutics

Price Movement
In the last 7 days, ZVSA stock has moved down by -7.3%
ZVSA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 113.0%

Zyversa Therapeutics Technicals Summary

Sell

Neutral

Buy

Zyversa Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Zyversa Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Zyversa Therapeutics Inc	7.48%	-68.23%	-86.47%	-99.96%	-99.96%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Zyversa Therapeutics Inc	0.0	0.0	NA	-12.43	-1.52	-0.25	NA	27.33
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Zyversa Therapeutics Inc	Buy	$2.7M	-99.96%	0.0	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Zyversa Therapeutics

variant pharmaceuticals is an orphan drug company leveraging advanced proprietary technologies to develop best-in-class drugs for patients with rare diseases. our accomplished leadership team, each with more than 15 years of demonstrated success in the biopharmaceutical and medical industries, focuses on assuring that our development efforts serve the needs of all our stakeholders: patients, health care providers, payors, and our investors. our evolving product pipeline is targeted to the $100+ billion orphan drug market. our lead orphan drug candidate is hydroxypropyl beta cyclodextrin (hpβcd) for chronic treatment of two orphan indications, var 200: focal segmental glomerulosclerosis (fsgs) and var 300: alport syndrome (as). both of these conditions are rare progressive forms of kidney disease associated with accumulation of cholesterol and lipids, contributing to impaired kidney function, ultimately leading to dialysis and/or kidney transplantation. hpβcd entraps and removes lipids

Organization	Zyversa Therapeutics
Employees	7
CEO	Mr. Stephen C. Glover
Industry	Miscellaneous

Management People of Zyversa Therapeutics

Name	Title
Mr. Stephen C. Glover	Co-Founder, Chairman, CEO & President
Mr. Peter Wolfe	CFO & Secretary
Ms. Karen A. Cashmere	Chief Commercial Officer
Ms. Melda Uzbil O'connell	Senior Vice President of Corporate Development
Dr. Pablo A. Guzman FACC, M.D.	Chief Medical Officer, Senior VP of Medical Affairs & Chairman of Renal Scientific Advisory Board

Important FAQs about investing in Zyversa Therapeutics from India :

What is Zyversa Therapeutics share price today?

Zyversa Therapeutics share price today stands at $1.15, Open: $1.17 ; Previous Close: $1.17 ; High: $1.17 ; Low: $1.06 ; 52 Week High: $25.00 ; 52 Week Low: $0.98. The stock opens at $1.17, after a previous close of $1.17. The stock reached a daily high of $1.17 and a low of $1.06, with a 52-week high of $25.00 and a 52-week low of $0.98.

Can Indians buy Zyversa Therapeutics shares?

Yes, Indians can invest in the Zyversa Therapeutics (ZVSA) from India.

With INDmoney, you can buy Zyversa Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Zyversa Therapeutics at zero transaction cost.

How can I buy Zyversa Therapeutics shares from India?

It is very easy to buy Zyversa Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Zyversa Therapeutics be purchased?

Yes, you can buy fractional shares of Zyversa Therapeutics with INDmoney app.

What are the documents required to start investing in Zyversa Therapeutics stocks?

To start investing in Zyversa Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.